Rushfeldt C, Smedsrød B
Department of Experimental Pathology and Anatomy, University of Tromsø, Norway.
Cancer Res. 1993 Feb 1;53(3):658-62.
A method was elaborated for high-yield 125I-trap labeling of rat colon carcinoma cells using conjugates of dichlorotriazine aminofluorescein and bovine serum albumin substituted with either N-acetylgalactosamine or N-acetylglucosamine as vehicles. Fluorescence microscopy revealed that the ligands accumulated in perinuclear vesicles that were probably lysosomes. Monensin inhibited accumulation by 40%, signifying receptor-mediated endocytosis. Competition experiments revealed that the same receptor(s) mediated endocytosis of the two neoglycoproteins. Accumulation of label was greatly enhanced in the absence of serum, resulting in a labeling efficiency of at least 15 cpm/cell, with no sign of toxic effects. At least 75% of the initially accumulated radioactivity resided in the cells 4 days after labeling. After that the loss of radioactivity was linear with time and stabilized at 1.1%/day for at least 2 weeks. Injection of labeled carcinoma cells i.v. into syngeneic rats revealed a very rapid clearance from the circulation. Isolation of the liver cells 24 h later revealed that a great proportion of the administered cells or their remnants had been engulfed by sinusoidal Kupffer and endothelial cells; the parenchymal cells contained a smaller proportion of label. In conclusion, we have developed a technique of labeling colon carcinoma cells with 125I and fluorescein utilizing specific lectin-like receptors for endocytosis. Since the label is trapped intralysosomally, it will also label Kupffer cells and other members of the reticuloendothelial system after internalization. These features make the procedure well suited for studies on the fate of the colon carcinoma cells after administration in vivo. Since the label is trapped intralysosomally for an extended length of time, parameters such as the formation of metastasis and elimination by phagocytosis can readily be determined.
已精心设计出一种方法,以二氯三嗪氨基荧光素与用N-乙酰半乳糖胺或N-乙酰葡糖胺取代的牛血清白蛋白的缀合物作为载体,对大鼠结肠癌细胞进行高产率的125I-阱标记。荧光显微镜检查显示,配体聚集在可能是溶酶体的核周小泡中。莫能菌素抑制聚集达40%,表明是受体介导的内吞作用。竞争实验显示,相同的受体介导这两种新糖蛋白的内吞作用。在无血清条件下,标记物的聚集显著增强,标记效率至少为15 cpm/细胞,且无毒性作用迹象。标记后4天,至少75%最初聚集的放射性仍存在于细胞中。此后,放射性的损失与时间呈线性关系,并在至少2周内稳定在1.1%/天。将标记的癌细胞经静脉注射到同基因大鼠体内后,发现其从循环中清除非常迅速。24小时后分离肝细胞发现,大部分注入的细胞或其残余物已被肝血窦的库普弗细胞和内皮细胞吞噬;实质细胞中所含的标记物比例较小。总之,我们已开发出一种利用特异性凝集素样受体进行内吞作用,用125I和荧光素标记结肠癌细胞的技术。由于标记物被困在溶酶体内,内化后它也会标记库普弗细胞和网状内皮系统的其他成员。这些特性使该方法非常适合研究体内给药后结肠癌细胞的命运。由于标记物在溶酶体内长时间被困,转移形成和吞噬清除等参数可很容易地确定。